Cargando…
Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
The neurological complications of infection by the mosquito-borne Zika virus (ZIKV) include Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating polyneuritis. GBS was first associated with recent ZIKV epidemics caused by the emergence of the ZIKV Asian lineage in South Pacific. Here, w...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003386/ https://www.ncbi.nlm.nih.gov/pubmed/33808706 http://dx.doi.org/10.3390/vaccines9030283 |
_version_ | 1783671677479026688 |
---|---|
author | Lebeau, Grégorie Frumence, Etienne Turpin, Jonathan Begue, Floran Hoarau, Jean-Jacques Gadea, Gilles Krejbich-Trotot, Pascale Desprès, Philippe Viranaicken, Wildriss |
author_facet | Lebeau, Grégorie Frumence, Etienne Turpin, Jonathan Begue, Floran Hoarau, Jean-Jacques Gadea, Gilles Krejbich-Trotot, Pascale Desprès, Philippe Viranaicken, Wildriss |
author_sort | Lebeau, Grégorie |
collection | PubMed |
description | The neurological complications of infection by the mosquito-borne Zika virus (ZIKV) include Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating polyneuritis. GBS was first associated with recent ZIKV epidemics caused by the emergence of the ZIKV Asian lineage in South Pacific. Here, we hypothesize that ZIKV-associated GBS relates to a molecular mimicry between viral envelope E (E) protein and neural proteins involved in GBS. The analysis of the ZIKV epidemic strains showed that the glycan loop (GL) region of the E protein includes an IVNDT motif which is conserved in voltage-dependent L-type calcium channel subunit alpha-1C (Ca(v)1.2) and Heat Shock 70 kDa protein 12A (HSP70 12A). Both VSCC-alpha 1C and HSP70 12A belong to protein families which have been associated with neurological autoimmune diseases in central nervous system. The purpose of our in silico analysis is to point out that IVNDT motif of ZIKV E-GL region should be taken in consideration for the development of safe and effective anti-Zika vaccines by precluding the possibility of adverse neurologic events including autoimmune diseases such as GBS through a potent mimicry with Heat Shock 70 kDa protein 12A (HSP70 12A). |
format | Online Article Text |
id | pubmed-8003386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80033862021-03-28 Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development Lebeau, Grégorie Frumence, Etienne Turpin, Jonathan Begue, Floran Hoarau, Jean-Jacques Gadea, Gilles Krejbich-Trotot, Pascale Desprès, Philippe Viranaicken, Wildriss Vaccines (Basel) Brief Report The neurological complications of infection by the mosquito-borne Zika virus (ZIKV) include Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating polyneuritis. GBS was first associated with recent ZIKV epidemics caused by the emergence of the ZIKV Asian lineage in South Pacific. Here, we hypothesize that ZIKV-associated GBS relates to a molecular mimicry between viral envelope E (E) protein and neural proteins involved in GBS. The analysis of the ZIKV epidemic strains showed that the glycan loop (GL) region of the E protein includes an IVNDT motif which is conserved in voltage-dependent L-type calcium channel subunit alpha-1C (Ca(v)1.2) and Heat Shock 70 kDa protein 12A (HSP70 12A). Both VSCC-alpha 1C and HSP70 12A belong to protein families which have been associated with neurological autoimmune diseases in central nervous system. The purpose of our in silico analysis is to point out that IVNDT motif of ZIKV E-GL region should be taken in consideration for the development of safe and effective anti-Zika vaccines by precluding the possibility of adverse neurologic events including autoimmune diseases such as GBS through a potent mimicry with Heat Shock 70 kDa protein 12A (HSP70 12A). MDPI 2021-03-19 /pmc/articles/PMC8003386/ /pubmed/33808706 http://dx.doi.org/10.3390/vaccines9030283 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Brief Report Lebeau, Grégorie Frumence, Etienne Turpin, Jonathan Begue, Floran Hoarau, Jean-Jacques Gadea, Gilles Krejbich-Trotot, Pascale Desprès, Philippe Viranaicken, Wildriss Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development |
title | Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development |
title_full | Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development |
title_fullStr | Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development |
title_full_unstemmed | Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development |
title_short | Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development |
title_sort | zika e glycan loop region and guillain–barré syndrome-related proteins: a possible molecular mimicry to be taken in account for vaccine development |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003386/ https://www.ncbi.nlm.nih.gov/pubmed/33808706 http://dx.doi.org/10.3390/vaccines9030283 |
work_keys_str_mv | AT lebeaugregorie zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT frumenceetienne zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT turpinjonathan zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT beguefloran zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT hoaraujeanjacques zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT gadeagilles zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT krejbichtrototpascale zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT despresphilippe zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment AT viranaickenwildriss zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment |